The spectrum of bone disease in end-stage renal failure - An evolving disorder

Kidney International

Volumn 43, Issue 2, 1993, Pages 436-442

  Sherrard, Donald J ^a   Hercz, Gavril ^b   Pei, York ^b   Maloney, Norma A ^b   Greenwood, Celia ^b   Manuel, Arif ^b   Saiphoo, Carl ^b   Fenton, Stanley S ^b   Segre, Gino V ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; CALCIUM; CALCIUM CARBONATE; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; BONE DISEASE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PARATHYROID FUNCTION; PERITONEAL DIALYSIS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ALUMINUM; COMPARATIVE STUDY; FEMALE; HUMAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGE; PARATHYROID HORMONES; PERITONEAL DIALYSIS; RENAL DIALYSIS; RENAL OSTEODYSTROPHY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.;

EID: 0027178439     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1993.64     Document Type: Article

References (38)

1. MALLUCHE H, FAUGERE M-C: Renal bone disease 1990: An unmet challenge for the nephrologist. Kidney Int 38:193-211, 1990
2. 3 intake: Emergence of an idiopathic adynamic bone disease not related to aluminum. Nephron 53:93-101, 1989
3. PEI Y, HERCZ G, GREENWOOD C, SHERRARD D, SEGRE G, MANUEL A, SAIPHOO C, FENTON S: Non-invasive prediction of aluminum bone disease in hemo- and peritoneal dialysis patients. Kidney Int 41:1374-1382, 1992
4. SHERRARD DJ, BAYLINK DJ, WERGEDAL JE, MALONEY N: Quantitative histological studies on the pathogenesis of uremic bone disease. J Clin Endo Metab 39:119-135, 1974
5. MALONEY NA, OTT SM, MILLER N, ALFREY AC, COBURN JW, SHERRARD DJ: Histological quantitation of aluminum in iliac bone from patients with renal failure. J Lab Clin Med 99:206-216, 1982
6. SHERRARD DJ, MALONEY NA: Single dose tetracycline labeling for bone histomorphometry. Am J Clin Pathol 91:682-687, 1989
7. SHERRARD DJ, OTT SM, MALONEY NA, ANDRESS D, COBURN JW: Uremic osteodystrophy: Classification, cause, and treatment, in Clinical Disorders of Bone and Mineral Metabolism, edited by FRAME B, POTTS JT JR, Amsterdam, Excerpta Medica, 1983, pp. 254-259
8. PARFITT M, DREZNER MK, GLORIEUX FH, KANIS JA, MALLUCHE H, MEUNIER PJ, OH SM, RECKER RR: Bone histomorphometry: Standardization of nomenclature, symbols and units. J Bone Miner Res 2:595-610, 1987
9. NUSSBAUM SR, ZAHRADNIK RJ, LAVIGNE JR, BRENNAN GL, NOZEWE-UNG K, KIM LY: Highly sensitive two-site immunoradiometric assay of parathyroid hormone and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 33:1364-1367, 1987
10. SAVORY J, WILS MR: Analytical methods for aluminum measurement. Kidney Int 29(Suppl):S24-27, 1986
11. MILLINER DS, NEBEKER HG, OTT SM, ANDRESS DL, SHERRARD DJ, ALFREY AC, SLATOPOLSKY EA, COBURN JW: Use of deferoxamine infusion test in the diagnosis of aluminum-related osteodystrophy. Ann Intern Med 101:775-780, 1984
12. KRAMER CY: Extension of multiple range tests to group means with unequal numbers of replications. Biometric 12:307-310, 1956
13. Statxact. Cytel Software Corp., Cambridge, Massachusetts, 1989
14. SAS Institute Inc. SAS/STAT User's Guide, Version 6. 4th ed., Cary, NC: SAS Institute Inc., 1989
15. SHERRARD DJ, BAYLINK D, WERGEDAL J: Bone disease in uremia. ASAIO Trans 28:412-415, 1972
16. ELLIS HA, PIERIDES AM, FEEST TG, WARD MK, KERR DNS: Histopathology of renal osteodystrophy with particular reference to the effects of 1-hydroxyvitamin D3 in patients treated by long term hemodialysis. Clin Endocrinol 7:315-385, 1977
17. OTT SM, MALONEY NA, COBURN JW, ALFREY AC, SHERRARD DJ: The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. N Engl J Med 307:709-714, 1982
18. SMITH AJ, FAUGERE MC, ABREO K, FANTI P, JULIAN B, MALLUCHE HH: Aluminum related bone disease in mild and advanced renal failure. Evidence for high prevalence and morbidity, and studies on etiology and diagnosis. Am J Nephrol 6:275-283, 1986
19. LLACH F, FELSENFELD AJ, COLEMAN MD, KEVENEV JJ, PEDERSEN JA, MADLOCK TR: The natural course of dialysis osteomalacia. Kidney Int 29:S74-S79, 1986
20. ANDRESS DL, NEBEKER HG, OTT SM, ENDRES DB, ALFREY AC, SLATOPOLSKY EA, COBURN JW, SHERRARD DJ: Bone histologic response to deferoxamine in aluminum-related bone disease. Kidney Int 31:1344-1350, 1987
21. KAYE M, HODSMAN AB, MALYNOWSKY L: Staining of bone for aluminum: Use of acid solochrome azurine. Kidney Int 37:1142-1147, 1990
22. HERCZ G, PEI Y, MANUEL A, SAIPHOO C, GOODMAN WG, SEGRE GV, SHERRARD DJ: Aplastic osteodystrophy without aluminum in dialysis patients. (abstract) Kidney Int 37:449, 1990
23. 3 in chronic renal failure. Effect of surface bone aluminum, in Vitamin D, Chemical, Biochemical and Clinical Update, edited by NORMAN AW, SCHAEFER K, VON HERRATH D, New York, Walter de Gruyter & Co, 1985, pp. 926-934
24. FAUGERE MC, MALLUCHE HH: Stainable aluminum and not aluminum content reflects bone histology in dialyzed patients. Kidney Int 30:717-722, 1986
25. COURNOT-WITMER C, ZINGRAFF J, PLACHOT JJ, ESCAIG F, LEFEVRE R, BOUMATI P, BOURDEAU A, GARABEDIAN M, GALLE P, BOURDON R, DRUEKE T, BALSAN S: Aluminum localization in bone from hemodialyzed patients: Relationship to matrix mineralization. Kidney Int 20:375-385, 1981
26. MALONEY NA, OTT SM, ALFREY AC, MILLER NL, COBURN JW, SHERRARD DJ: Histological quantitation of aluminum in iliac bone from patients with renal failure. J Lab Clin Med 99:206-216, 1982
27. MALLUCHE HH, FAUGERE M-C, SMITH AJ, FRIEDLER RM: Aluminum intoxication of bone in renal failure: Fact or fiction? Kidney Int 29(Suppl 18):70-73, 1986
28. ANDRESS DL, MALONEY NA, ENDRES DB, SHERRARD DJ: Aluminum-associated bone disease in chronic renal failure: High prevalence in a long-term dialysis population. J Bone Miner Res 1:391-398, 1986
29. BERLAND Y, GRANDVIULLEMIN M, CHARHON S, OLMER M, ANDONIAN C: Aluminum and renal osteodystrophy in chronic uremia. Kidney Int 28(Suppl 17):183-187, 1985
30. QUARLES LK, DENNIS VW, GITELMAN HJ, HARRELSON JM, DREZNER MK: Aluminum deposition at the osteoid-bone interface. An epiphenomenon of the osteomalacia state in vitamin D-deficient dogs. J Clin Invest 75:1441-1447, 1985
31. PHELPS KR, VIGORITA VJ, BANSAL M, EINHORN TA: Histochemical demonstration of iron but not aluminum in a case of dialysisassociated osteomalacia. Am J Med 84:775-780, 1988
32. MORTON AR, HERCZ G: Hypercalcemia in dialysis patients: Comparison of diagnostic methods. Dial Transplant 20:661-694, 1991
33. RAPOPORT J, SHANY S, CHAIMOVITZ C: Continuous ambulatory peritoneal dialysis and vitamin D. Nephron 48:1-3, 1988
34. ANDRESS DL, HERCZ G, KOPP JB, ENDRES DB, NORRIS KC, COBURN JW, SHERRARD DJ: Bone histomorphometry of renal osteodystrophy in diabetic patients. J Bone Miner Res 2:525-531, 1987
35. 3 in chronic renal failure. Kidney Int 33:1044-1058, 1988
36. BRICKMAN AS, SHERRARD DJ, JOWSEY J, BAYLINK DJ, NORMAN AW, MASSRY SG, BISHOP J, COBURN JW: 1,25-dihydroxycholecalciferol in uremic osteodystrophy. Arch Intern Med 134:883-888, 1974
37. BRICKMAN AS, COBURN JW, SHERRARD DJ, WONG EGC, NORMAN AW, SINGER FR: Clinical effects of 1,25-dihydroxy vitamin D in uremic patients with overt osteodystrophy. Contrib Nephrol 18:29-41, 1980
38. ANDRESS DL, NORRIS KC, COBURN JW, SLATOPOLSKY EA, SHERRARD DJ: Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med 321:274-279, 1989